logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (ii) Percentage distribution of new outpatient clients by primary drug for age at first use

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates9.724.944.744.84239.540.537.3233907049
Cocaine14.427.237.642.445.745.941.132.3235946559
Stimulants6.39.753.52.62.32.31.254341421
Hypnotics and sedatives10.71.324.16.18.819.91203429
Hallucinogens1.11.20.70.40.10.300.2719214
Volatile substances0.80.20.10.100.10.10.316346
Cannabis 65.435.210.16.24.95.43.97.6223916360
Other substances 1.40.80.40.60.60.43.31.3625594
Total1107936006164737109345318229736047751922672

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, MT, NL, SK, FI, SE. 

 Last data available from Spain refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008